Is the Tax System Neutral in India: An Analysis of Tax Treatment of Selected Funds
Finance and Capital Markets (formerly Derivatives & Financial Instruments) · 2020
DOI: 10.59403/11t0a1n ↗Kurz gefasst
Fachartikel in der Zeitschrift Finance and Capital Markets (formerly Derivatives & Financial Instruments), 2020. Verfasst von S. (Suranjali) Tandon. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 84 Literaturangaben.
Abstract (Originalsprache)
One of the fundamental principles of taxation is neutrality. In finance this assumes significance since the decision to invest must not depend on tax. It is also true that any departure from neutrality must be grounded in sound economic purpose. Neutrality is desirable for well-functioning financial markets. Investment funds In this article, the term “fundˮ includes the selected investment vehicles including securitization trusts. This should not be confused with the nomenclature used in Income Tax Act 1961. form an integral part of financial markets. These can operate through different structures and invest in different asset classes. Some of these funds can channel resources to sectors that are considered key for growth and development. Selecting AIF, REIT, InvITs and securitization trusts in India the tax system is compared for these and evaluated. It is found that the existing structure is not neutral and this article presents scope for policy change.
Zitieren
APA
Tandon, S. S. (2020). Is the Tax System Neutral in India: An Analysis of Tax Treatment of Selected Funds. Finance and Capital Markets (formerly Derivatives & Financial Instruments). https://doi.org/10.59403/11t0a1n
Vancouver
Tandon SS. Is the Tax System Neutral in India: An Analysis of Tax Treatment of Selected Funds. Finance and Capital Markets (formerly Derivatives & Financial Instruments). 2020. doi:10.59403/11t0a1n
BibTeX
@article{Tandon2020,
author = {Tandon, S. (Suranjali)},
title = {Is the Tax System Neutral in India: An Analysis of Tax Treatment of Selected Funds},
journal = {Finance and Capital Markets (formerly Derivatives & Financial Instruments)},
year = {2020},
doi = {10.59403/11t0a1n}
}
EUVIMED